These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9599697)

  • 21. A new corneal epithelial biomimetic 3D model for in vitro eye toxicity assessment: Development, characterization and applicability.
    da Silva ACG; Chialchia AR; de Castro EG; E Silva MRL; Arantes DAC; Batista AC; Kitten GT; Valadares MC
    Toxicol In Vitro; 2020 Feb; 62():104666. PubMed ID: 31629070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcutaneous electrical resistance: application in predicting skin corrosives.
    Lewis RW; Basketter DA
    Curr Probl Dermatol; 1995; 23():243-55. PubMed ID: 9035919
    [No Abstract]   [Full Text] [Related]  

  • 23. [Irritant contact dermatitis. Part I. Epidemiology, etiopathogenesis and clinical manifestation].
    Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
    Med Pr; 2008; 59(5):409-19. PubMed ID: 19227886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens.
    Galbiati V; Mitjans M; Lucchi L; Viviani B; Galli CL; Marinovich M; Corsini E
    Toxicol In Vitro; 2011 Apr; 25(3):724-32. PubMed ID: 21182927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative methods for eye and skin irritation tests: an overview.
    Vinardell MP; Mitjans M
    J Pharm Sci; 2008 Jan; 97(1):46-59. PubMed ID: 17701961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IRAG working group 6. Guidelines for the evaluation of eye irritation alternative tests: criteria for data submission. Interagency Regulatory Alternatives Group.
    Scala RA; Springer J
    Food Chem Toxicol; 1997 Jan; 35(1):13-22. PubMed ID: 9100812
    [No Abstract]   [Full Text] [Related]  

  • 27. An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions.
    Homey B; von Schilling C; Blümel J; Schuppe HC; Ruzicka T; Ahr HJ; Lehmann P; Vohr HW
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):83-94. PubMed ID: 9875302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Isolated Chicken Eye test to replace the Draize test in rabbits.
    Prinsen MK; Hendriksen CFM; Krul CAM; Woutersen RA
    Regul Toxicol Pharmacol; 2017 Apr; 85():132-149. PubMed ID: 28192172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of alternative methods for toxicity testing.
    Bruner LH; Carr GJ; Curren RD; Chamberlain M
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A data-based exploration of the adverse outcome pathway for skin sensitization points to the necessary requirements for its prediction with alternative methods.
    Benigni R; Bossa C; Tcheremenskaia O
    Regul Toxicol Pharmacol; 2016 Jul; 78():45-52. PubMed ID: 27090483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories.
    Na M; O'Brien D; Gerberick GF; Kern PS; Lavelle M; Lee I; Parakhia R; Ryan C; Api AM
    Regul Toxicol Pharmacol; 2022 Apr; 130():105128. PubMed ID: 35104615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols.
    Tornier C; Rosdy M; Maibach HI
    Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
    Welss T; Basketter DA; Schröder KR
    Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hemoglobin denaturation as an alternative to the Draize test for predicting eye irritancy of surfactants.
    Mitjans M; Infante MR; Vinardell MP
    Regul Toxicol Pharmacol; 2008 Nov; 52(2):89-93. PubMed ID: 18602964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of dermal sensitizers in pharmaceutical manufacturing.
    Winkler GC; Perino C; Araya SH; Bechter R; Kuster M; Lovsin Barle E
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):501-5. PubMed ID: 26028366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.
    MacKay C; Davies M; Summerfield V; Maxwell G
    ALTEX; 2013; 30(4):473-86. PubMed ID: 24173169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential in vitro epidermal equivalent assay to determine sensitizer potency.
    dos Santos GG; Spiekstra SW; Sampat-Sardjoepersad SC; Reinders J; Scheper RJ; Gibbs S
    Toxicol In Vitro; 2011 Feb; 25(1):347-57. PubMed ID: 20940038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An approach to the development of in vitro toxicological methods.
    Goldberg AM
    Food Chem Toxicol; 1985 Feb; 23(2):205-8. PubMed ID: 4040067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.